Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.16
+0.14 (0.30%)
At close: Mar 6, 2026, 4:00 PM EST
46.16
0.00 (0.00%)
After-hours: Mar 6, 2026, 5:08 PM EST

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,5333,1471,4341,2361,044813
Market Cap Growth
148.13%119.41%16.06%18.37%28.45%-32.56%
Enterprise Value
3,1422,7431,2011,042859.38636.69
Last Close Price
46.1641.2519.7817.5414.9811.77
PE Ratio
61.5555.00-32.9787.705.76-5.12
Forward PE
35.8927.3242.93---
PEG Ratio
0.97-----
PS Ratio
5.234.643.394.574.7421.09
PB Ratio
6.195.543.272.822.644.39
P/TBV Ratio
6.425.743.222.882.664.36
P/FCF Ratio
26.0023.0756.4493.83183.11-6.41
P/OCF Ratio
25.7022.8155.8492.92179.79-6.44
EV/Sales Ratio
4.644.052.843.853.9016.52
EV/EBITDA Ratio
39.8934.82-27.34-45.5870.59-4.13
EV/EBIT Ratio
40.6935.52-26.32-41.3587.93-4.06
EV/FCF Ratio
23.0320.1047.2579.10150.72-5.02
Debt / Equity Ratio
0.020.020.020.030.010.03
Debt / EBITDA Ratio
0.120.12-0.22-0.540.49-0.04
Debt / FCF Ratio
0.070.070.390.931.04-0.05
Net Debt / Equity Ratio
-0.71-0.71-0.53-0.44-0.47-0.95
Net Debt / EBITDA Ratio
-5.14-5.145.328.49-15.171.14
Net Debt / FCF Ratio
-2.97-2.97-9.20-14.74-32.391.39
Asset Turnover
1.011.010.760.550.640.13
Inventory Turnover
1.911.912.121.271.814.95
Quick Ratio
3.093.092.843.584.484.15
Current Ratio
3.793.793.304.345.164.38
Return on Equity (ROE)
11.73%11.73%-9.85%3.37%63.10%-63.55%
Return on Assets (ROA)
18.04%15.35%-6.64%-14.54%-41.30%-53.33%
Return on Invested Capital (ROIC)
49.50%42.12%-14.09%-28.79%-118.29%-4448.43%
Return on Capital Employed (ROCE)
13.98%13.98%-9.68%-5.76%3.25%-61.96%
Earnings Yield
1.66%1.82%-3.03%1.14%17.36%-19.54%
FCF Yield
3.85%4.33%1.77%1.07%0.55%-15.59%
Buyback Yield / Dilution
-1.05%-1.05%-0.86%-0.12%-0.24%-0.72%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q